These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 33748490)

  • 81. Altered fecal bacterial composition correlates with disease activity in inflammatory bowel disease and the extent of IL8 induction.
    Heidarian F; Alebouyeh M; Shahrokh S; Balaii H; Zali MR
    Curr Res Transl Med; 2019 May; 67(2):41-50. PubMed ID: 30685379
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Dysbiosis and Ecotypes of the Salivary Microbiome Associated With Inflammatory Bowel Diseases and the Assistance in Diagnosis of Diseases Using Oral Bacterial Profiles.
    Xun Z; Zhang Q; Xu T; Chen N; Chen F
    Front Microbiol; 2018; 9():1136. PubMed ID: 29899737
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Combined Signature of the Fecal Microbiome and Plasma Metabolome in Patients with Ulcerative Colitis.
    Sun M; Du B; Shi Y; Lu Y; Zhou Y; Liu B
    Med Sci Monit; 2019 May; 25():3303-3315. PubMed ID: 31055592
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Therapeutic effect of n-butanol fraction of Huang-lian-Jie-du Decoction on ulcerative colitis and its regulation on intestinal flora in colitis mice.
    Yuan Z; Yang L; Zhang X; Ji P; Wei Y
    Biomed Pharmacother; 2020 Jan; 121():109638. PubMed ID: 31810136
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Partners of patients with ulcerative colitis exhibit a biologically relevant dysbiosis in fecal microbial metacommunities.
    Chen GL; Zhang Y; Wang WY; Ji XL; Meng F; Xu PS; Yang NM; Ye FQ; Bo XC
    World J Gastroenterol; 2017 Jul; 23(25):4624-4631. PubMed ID: 28740351
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Comparison of Metabolites and Gut Microbes between Patients with Ulcerative Colitis and Healthy Individuals for an Integrative Medicine Approach to Ulcerative Colitis-A Pilot Observational Clinical Study (STROBE Compliant).
    Kim CH; Lee YU; Kim KH; Kang S; Kang GH; Chu H; Lee S
    Diagnostics (Basel); 2022 Aug; 12(8):. PubMed ID: 36010319
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Quyushengxin Formula Causes Differences in Bacterial and Phage Composition in Ulcerative Colitis Patients.
    Yang H; Gan D; Li Y; Wang X; Jin L; Qin K; Cui C; Wu J; Wang Z
    Evid Based Complement Alternat Med; 2020; 2020():5859023. PubMed ID: 32454865
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [SURGICAL TREATMENT OF ULCERATIVE COLITIS. HISTORY].
    Knyazev AV; Shkurko TV; Vardanyan AV; Romanov RI
    Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med; 2021 Aug; 29(Special Issue):1358-1367. PubMed ID: 34792890
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Intestinal Ultrasound to Assess Disease Activity in Ulcerative Colitis: Development of a Novel UC-Ultrasound Index.
    Allocca M; Bonovas S; Danese S
    J Crohns Colitis; 2021 Aug; 15(8):1405-1406. PubMed ID: 33493305
    [No Abstract]   [Full Text] [Related]  

  • 90. A Case of Transient Ischemic Attack in a patient with Ulcerative Colitis.
    Valavanis A; Tegos T
    Hippokratia; 2013 Jan; 17(1):79-80. PubMed ID: 23935351
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Failure of Seres's phase II ulcerative colitis programme renews microbiome concerns.
    Mullard A
    Nat Rev Drug Discov; 2021 Sep; 20(9):658. PubMed ID: 34363025
    [No Abstract]   [Full Text] [Related]  

  • 92. Editorial: Ulcerative colitis disease therapy: Unveiling the molecular mechanisms of well-defined composition from natural plants.
    Tao Y; Qin K; Li H; Hu L
    Front Pharmacol; 2023; 14():1172160. PubMed ID: 37007017
    [No Abstract]   [Full Text] [Related]  

  • 93. Corrigendum: Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management.
    Harbord M; Eliakim R; Bettenworth D; Karmiris K; Katsanos K; Kopylov U; Kucharzik T; Molnár T; Raine T; Sebastian S; de Sousa HT; Dignass A; Carbonnel F;
    J Crohns Colitis; 2017 Dec; 11(12):1512. PubMed ID: 29088340
    [No Abstract]   [Full Text] [Related]  

  • 94. The Classification of a Group of Escherichia Isolated from the Intestinal Tract of Patients with Ulcerative Colitis.
    Nicholls EE; Saltz HP
    J Bacteriol; 1936 Mar; 31(3):313-9. PubMed ID: 16559889
    [No Abstract]   [Full Text] [Related]  

  • 95. European evidence-based Consensus on the management of ulcerative colitis: Special situations.
    Biancone L; Michetti P; Travis S; Escher JC; Moser G; Forbes A; Hoffmann JC; Dignass A; Gionchetti P; Jantschek G; Kiesslich R; Kolacek S; Mitchell R; Panes J; Soderholm J; Vucelic B; Stange E;
    J Crohns Colitis; 2008 Mar; 2(1):63-92. PubMed ID: 21172196
    [No Abstract]   [Full Text] [Related]  

  • 96. Chronic Ulcerative Colitis: Part II.
    Reed AC
    Cal West Med; 1939 Jul; 51(1):32-5. PubMed ID: 18745234
    [No Abstract]   [Full Text] [Related]  

  • 97. Chronic Ulcerative Colitis: Part I.
    Reed AC
    Cal West Med; 1939 Jun; 50(6):402-3. PubMed ID: 18745176
    [No Abstract]   [Full Text] [Related]  

  • 98. Recent Studies on Ulcerative Colitis.
    Can Med Assoc J; 1962 Oct; 87(17):923-4. PubMed ID: 20327284
    [No Abstract]   [Full Text] [Related]  

  • 99. Ulcerative Colitis: Studies of Personality.
    Wittkower E
    Br Med J; 1938 Dec; 2(4069):1356-60. PubMed ID: 20782002
    [No Abstract]   [Full Text] [Related]  

  • 100. Ulcerative Colitis.
    Rogers AG
    Can Med Assoc J; 1956 Apr; 74(8):660. PubMed ID: 20325268
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.